Median Technologies (ALMDT) | Stock Overview & Key Data
Median Technologies Performance Comparison
Stock Range
Today's Range
52 Week Range
All-Time High: €18.32 on October 18, 2021
Explore how other French stocks compare to their 52-week ranges: View FR Market 52-Week Insights
Key Statistics
Financial Highlights
Annual Income Flow
2024
Peer Performance Comparison
| Company | Market Cap | 1W | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Median Technologies
ALMDT
|
188.62M Mid-cap | -3.32% | 0.00% | 2.91% | 52.78% | 12.76% | 141.21% | -23.08% | -60.40% | -44.83% | -35.48% | -35.48% |
|
Eurobio Scientific
ALERS
|
229.56M Mid-cap | 1.34% | 1.34% | 0.89% | -6.39% | -6.00% | -12.55% | 52.53% | 19.00% | 178.75% | -5.51% | -5.51% |
|
Guerbet S.A
GBT
|
127.29M Small-cap | -4.57% | -1.21% | 19.63% | -27.01% | -33.63% | -53.04% | -42.84% | -67.54% | -81.86% | -38.17% | -38.17% |
|
Affluent Medical
AFME
|
122.22M Small-cap | -4.82% | 9.09% | 26.32% | 134.97% | 88.76% | 146.48% | 171.32% | -55.97% | -55.97% | -55.97% | -55.97% |
|
Mauna Kea
ALMKT
|
37.44M Small-cap | 0.00% | -5.56% | -15.00% | 142.86% | 112.50% | 30.77% | -72.58% | -72.58% | -72.58% | -72.58% | -72.58% |
|
Diagnostic Medical
ALDMS
|
34.47M Small-cap | 6.56% | 0.00% | 2.36% | 4.84% | 1.56% | 3.23% | -10.49% | -15.23% | -28.89% | -39.91% | -39.91% |
Ownership & Short Interest
Calculate Your Median Technologies Investment Returns
Long-Term Investment Performance Analysis
Median Technologies stock price in Jul 2016 was €8.99, A €1,000.00 lump sum investment in Median Technologies made 9 years ago would be worth approximately €550.61 today, representing a negative return of -44.94%. This translates to an annualized return (CAGR) of -5.84%.
9 Years 10 Months Investment Scenario (Jul 2016 - Jun 2026)
Investment Breakdown
Value Comparison
Disclaimer: This calculator is for informational purposes only and does not consider taxes, fees, or other costs associated with investing. Past performance does not guarantee future results.
Frequently Asked Questions
- What is ALMDT's 52-week high and low?
- In the last 52 weeks, Median Technologies reached a high of €7.27 (on February 9, 2026) and a low of €1.19 (on June 18, 2025).
- What is the market cap and P/E ratio for ALMDT?
- Curious about Median Technologies's size and valuation? Its market capitalization stands at 188.62M. When it comes to valuation, the P/E ratio (trailing twelve months) is -3.61, and the forward P/E (looking ahead) is -11.56.
- Does ALMDT pay dividends? If so, what's the yield?
- As for dividends, Median Technologies isn't currently offering a significant yield, or that specific data isn't available right now.
- Who are Median Technologies's main competitors or similar companies to consider before investing?
When looking at Median Technologies, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:
Company Mkt Cap Sector Industry 1Y Return 3Y Return Eurobio Scientific
ALERS229.56M Healthcare Medical Devices -12.55% 52.53% Guerbet S.A
GBT127.29M Healthcare Medical Devices -53.04% -42.84% Affluent Medical
AFME122.22M Healthcare Medical Devices 146.48% 171.32% Mauna Kea
ALMKT37.44M Healthcare Medical Devices 30.77% -72.58% Diagnostic Medical
ALDMS34.47M Healthcare Medical Devices 3.23% -10.49% For a more comprehensive list, please see the Peer Performance Comparison table on this page.
- What are the key financial health indicators for Median Technologies S.A.? (e.g., ROE, Debt/Equity)
- To get a sense of Median Technologies's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is 74.31%, the Debt to Equity ratio from the most recent quarter is -1.15, and its Gross Profit Margin stands at N/A.
- What is the recent revenue and earnings growth for ALMDT?
- Looking at Median Technologies's growth, its revenue over the trailing twelve months (TTM) was €23M. Compared to the same quarter last year (YoY), quarterly revenue grew by 3.90%, and quarterly earnings saw a YoY growth of N/A.
- How much of ALMDT stock is held by insiders and institutions?
- Wondering who owns Median Technologies stock? Company insiders (like executives and directors) hold about 13.13% of the shares, while institutional investors (such as mutual funds and pension funds) own approximately 10.84%.
For more common questions about our data, please visit our About Data page.
Data is provided for informational purposes only. Devyara does not guarantee the accuracy of the data displayed.